Through the continued discovery and analysis of cytogenetic abnormalities in MDS and MPN and the consequences that these abnormalities exert on disease biology, the healthcare community has been provided with refined diagnostic and prognostic algorithms along with defined molecular targets for disease management and therapy.
This Expert Perspectives activity is a conversation between Drs. Srdan Verstovsek, Elizabeth O. Hexner and Guillermo Garcia-Manero discussing the key findings presented during the 2015 US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes Congress and providing insight into the importance of these findings as they are introduced into the clinic.
Earn accreditation for this activity at the following location:
© 2015 Imedex, LLC.